Mortality among Parkinson Patients Treated with L-Dopa Combined with a Decarboxylase Inhibitor
作者:
H. Zumstein,
J. Siegfried,
期刊:
European Neurology
(Karger Available online 1976)
卷期:
Volume 14,
issue 5
页码: 321-327
ISSN:0014-3022
年代: 1976
DOI:10.1159/000114756
出版商: S. Karger AG
关键词: L-Dopa;Decarboxylase inhibitor;Mortality;Parkinson’s disease
数据来源: Karger
摘要:
Since L-dopa in combination with a decarboxylase inhibitor is currently the most effective therapy available for treatment of Parkinson’s disease, the authors compare the actual causes of death in a large series of treated Parkinson patients with a normal population and with previous studies. This investigation shows that the mortality of correctly treated Parkinson patients lies within the range of the expected mortality of a group of a normal population comparable in age and sex. The risk of death for a Parkinson patient is therefore no longer higher than for the normal populatio
点击下载:
PDF
(678KB)
返 回